Back to search results

Viome Nutritional Programs for Metabolic Health

This study is testing two different Viome nutritional programs to see if they can improve health for people with metabolic conditions. The programs are called the VIOME Precision Nutrition Program and Viome-designed condition-based supplements. Both programs involve supplements, diet advice, and app coaching. You might be able to join if you are a US resident between 25 and 75 years old, can speak and read English, and have obesity. The study will look at how well these programs work after about 4 months. The current status of this study is unclear, so it's not known if they are actively enrolling participants.

Study design
This interventional study plans to enroll 150 participants who will be randomly assigned to one of three groups: a placebo group, the VIOME Precision Nutrition Program, or Viome-designed condition-based supplements.
What's involved
You would complete a survey when you join and follow trial instructions for approximately 4 months. This study is direct to participant and does not involve clinic visits.
Compensation
Not stated in the trial record.
Follow-up
Participants will be followed for approximately 4 months, which is when the main results are measured.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT05564273

Viome Nutritional Programs to Improve Clinical Outcomes for Metabolic Conditions

Recruiting
NAAges 25–75InterventionalTreatment
Viome
~150 participants
Updated 2025-01-29 on ClinicalTrials.gov
What's tested:VIOME Precision Nutrition ProgramVIOME-designed condition-based supplements

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Efficacy of VIOME's designed condition based supplements (VCS)
Measured over ~4months
+1 more outcome measured

Conditions

Metabolic Health

Explore related trials

ObesityGlucose

Where it's being run

1 sites across 1 states
Washington1

Study leadership

  • Momchilo Vuyisich · PRINCIPAL_INVESTIGATOR · Viome Life Sciences

Who to contact

Mory Mehrtash
[email protected]
(425) 300-6933
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Resident of the United States
Females and males ages 25-75 (inclusive)
Able to speak and read English
No unexplained weight loss, fevers, anemia, or blood in stool
Willing and able to follow the trial instructions, as described in the recruitment letter
Signed and dated informed consent prior to any trial-specific procedures.
Fasting insulin level \>=15 uIU/mL or fasting glucose \>= 100 mg/dL within the last 3 months, verified from medical records

Exclusion

Unwilling to change current diet
Unwilling to go to Quest
Prior use of Viome products or services
Antibiotic use in the previous 4 weeks
Women who are pregnant (current or planned in the next 4 months), or breastfeeding
\< 90 days postpartum
Active infection
Unable or unwilling to use Viome's App on an iPhone or Android smartphone
Significant diet or lifestyle changes in the previous 1 month
IBD diagnosis
Use of investigational drugs, products or devices within 1 month prior to and 4 months after the start of the trial
Cancer therapy within the previous 1 year
Major surgery in the last 6 months or planned in the next 4 months
Current (or previous) use of medications that increase insulin (sulfonylureas, such as glimepiride, glipizide, glyburide, etc.)
Current (or previous) use of exogenous insulin (such as Tresiba, Lantus, Toujeo, Levemir, Humalog, Novolog, Apidra, Fiasp, etc.)
Prescribed any drug(s) that may interact with the supplement formulations
Have any medical condition or allergy that may interact with, or prevents the healthy consumption of the supplements such as:
Allergies to any study-specific supplement ingredients
Currently on a specific diet:
Gastrointestinal disease including:
GI surgery except:
Appendectomy and benign polypectomy
Esophagitis
Celiac disease
GI malignancy or obstruction
Peptic Ulcer Disease
Duodenal or gastric ulcer disease

What this trial measures

  • Efficacy of VIOME's designed condition based supplements (VCS)~4months

    Number of participants that show an improvement in metabolic health compared to baseline survey assessment.

  • Efficacy of VIOME Precision Nutrition Program (VPNP)~4 months

    Number of participants that show an improvement in metabolic health compared to baseline survey assessment.